Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Nogin announces compliance with Nasdaq listing rule regarding form 10-Q filing
Post Content Post Views: 91
China ministry seeks more fever clinics to combat respiratory illness surge
Post Content Post Views: 99
Pro Research: Wall Street eyes Oracle’s cloud growth amid AI surge
Post Content Post Views: 102
White House invests billions in electric vehicle supply chain
Post Content Post Views: 95
Fed Chair Powell calls talk of cutting rates ‘premature’ and says more hikes could happen
Federal Reserve Chairman Jerome Powell on Friday pushed back on market expectations for aggressive interest rate cuts ahead. Post Views: 100
Scrutiny Intensifies Over Senator Smith’s Timely Investment in Tactile Systems
Post Content Post Views: 105